Litecoin has shown some stabilization at a critical historical support that can be considered as an opportunity for it to rebound to approximately $90.Litecoin has shown some stabilization at a critical historical support that can be considered as an opportunity for it to rebound to approximately $90.

Litecoin Holders Defend Key Support, Eyes Rebound Toward $90

Litecoin (LTC) is establishing itself in a stable position near a long-term support area as weekly selling pressure appears to be slowing. Historical buying has consistently occurred at current price ranges. If the price can continue to hold above this level, the next major upside would be toward the $90 price level.

Litecoin Has Started Its Next Move Up

Matthew Dixon, a well-known cryptocurrency analyst, spotted the potential for a bounce in Litecoin from its long-term support level. Dixon noted that Litecoin could be showing an early indication of a possible bounce.

Dixon added that he could potentially see a “hidden” bullish divergence forming on the weekly chart. A bull divergence forms when price action is relatively flat or trending lower while momentum is building.

Such conditions normally develop in an accumulation phase of the market, as opposed to an extended downtrend. He went on to state that he believes long-term holders are still holding their positions as volatility decreases.

Source: X

Also Read | Litecoin (LTC) Holds $74 Support Zone as Analyst Targets $285

Litecoin Remains Closely Tied To Long Term Trend Indicators

Litecoin’s price action remains very close to its 200-week exponential moving average (200 EMA). Price has historically reacted strongly to this average, thereby validating the technical significance of the average.

When the price is holding above or near the 200 EMA, it is generally seen as a sign that long-term support exists. The Litecoin price action has been finding additional support at significant Fibonacci retracement levels and the 200 EMA.

In the past, these Fibonacci retracement levels have represented long-term demand as opposed to short-term speculative selling. As such, when price action is around these levels, it is typically indicative of the market’s uncertainty as to which direction price will go next, and not a breakdown of the current trend.

EMA and Fibonacci. Source: TradingView

Litecoin’s Selling Pressure Appears To Be Waning

On the weekly chart, the MACD is showing that bearish momentum is waning. As the histogram bars are becoming smaller, it is clear that the selling pressure is not accelerating.

While a bullish crossover has not been created on the MACD, momentum appears to be weakening. The RSI also provides evidence that bears are losing momentum.

Even though Litecoin has recently shown significant weakness, the RSI is above extreme oversold levels. This means that sellers have had difficulty pushing the RSI into the extreme oversold territory.

There is even a hidden bullish divergence on the RSI, consistent with Dixon’s belief in the underlying strength of LTC. All of the momentum indicators appear to indicate that the price is stabilizing and will not continue downward.

MACD and RSI. Source: TradingView

If the support at the current levels holds, then a rebound towards the $90 price zone may become the new upside objective. That level is a past resistance level and has psychological importance. A move up to that level would represent a continued upward movement within a larger consolidation zone.

Also Read | Litecoin (LTC) Slips After Bearish Weekly Close as $71.40 Resistance Caps Recovery

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Gold Hits $3,700 as Sprott’s Wong Says Dollar’s Store-of-Value Crown May Slip

Gold Hits $3,700 as Sprott’s Wong Says Dollar’s Store-of-Value Crown May Slip

The post Gold Hits $3,700 as Sprott’s Wong Says Dollar’s Store-of-Value Crown May Slip appeared on BitcoinEthereumNews.com. Gold is strutting its way into record territory, smashing through $3,700 an ounce Wednesday morning, as Sprott Asset Management strategist Paul Wong says the yellow metal may finally snatch the dollar’s most coveted role: store of value. Wong Warns: Fiscal Dominance Puts U.S. Dollar on Notice, Gold on Top Gold prices eased slightly to $3,678.9 […] Source: https://news.bitcoin.com/gold-hits-3700-as-sprotts-wong-says-dollars-store-of-value-crown-may-slip/
Share
BitcoinEthereumNews2025/09/18 00:33
YouTube Advertising Formats: A Complete Guide for Marketers

YouTube Advertising Formats: A Complete Guide for Marketers

In today’s fast-evolving digital landscape, YouTube has emerged as one of the most powerful platforms for marketers looking to engage audiences through video. With
Share
Techbullion2026/01/21 01:49
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11